The therapeutic benefits of mindfulness and meditation are well researched and established as effective approaches in managing anxiety, depression, stress, attentional deficits, hyper-reactivity to traumatic events, and cardiovascular health. Although the techniques of meditation are simple, many people — clients and therapists alike — find it hard to get started and to establish their meditation practice so that it becomes a lasting habit.
Muse, a brain-sensing headband device, can help you train yourself and your clients to meditate. Through EEG technology, Muse allows you to monitor your progress as you meditate. By providing tangible feedback on the brain’s activity, Muse can help encode the meditative process in the body’s conscious awareness and thus facilitate access to the meditative state in a reliable and reproducible manner.
In this workshop, you will learn how Muse was developed and see the latest research on how Muse can harness brain science to improve therapeutic outcomes, as well as how to integrate it into clinical practice for in-session training or as a way to facilitate compliance and engagement.
Led by the developers of Muse, this one-day symposium brings together Muse co-founder Ariel Garten, researcher Graeme Moffat, and clinicians Laurie Wells and Michael Decaire to discuss ways in which personal EEG devices can be integrated into your personal practice and in clinical settings.
9:10 am – 9:45 am – How Muse Was Developed (Ariel Garten)
Muse, the brain-sensing headband, is a clinical-grade EEG that is used in a wide variety of clinical and therapeutic contexts. Ariel Garten is the co-founder of Muse and will take you through an introduction to the device and an overview of how it works, how it is used as a meditation device, and how it came to be developed.
You will learn —
• What Muse, the brain-sensing headband, is
• What brainwaves are, what they mean, and how Muse works
• About brainwave technology and how Muse came to be developed from it
9:45 am – 10:50 am – How Muse Harnesses Brain Research to Improve Outcomes and Empower Clinicians and Scientists (Graeme Moffat)
Muse is a powerful meditation learning aid for consumers, clinicians, and patients, and a powerful research tool for psychologists and neuroscientists around the world. This session will cover the history and application of EEG in brain health, meditation, and its neural correlates, and the extensive clinical and basic research being conducted internationally.
You will learn —
• How EEG works, how it interacts with mobile technology, and how it is applied in research and in neurofeedback
• How Muse is helping psychologists and cognitive scientists take their research and teaching outside of the lab
• How you can conduct or get involved in Muse-related brain research projects across Canada and around the world
10:50 am – 12:15 pm – Using MUSE in Practice and Community-Based Settings (Laurie Wells)
Muse will be presented as a mindfulness and meditation tool that can be utilized in a variety of modalities, ranging from personal practice to group work, and with various populations (for example, serious and persistent mental illness survivors, athletes, students, teachers, and clinicians). You will learn about the opportunities and challenges in using Muse in these settings, as well as possible applications for assisting individuals, couples, families, classes, or school programs.
You will learn —
• How Muse can be used with individuals and groups
• About the practical aspects of using Muse in a range of settings, from single-use to ongoing use
• How to adapt the use of MUSE to specific populations and add it as a valuable tool to your personal practice and clinical practice
1:30 pm – 4:40 pm – Applying Muse Brain Biofeedback Technology in Therapy (Michael Decaire)
Michael Decaire will demonstrate through case studies and analysis how personal feedback technology such as Muse can be a key component of a psychotherapy practice. Michael will walk you through a variety of client cases in which Muse was either the primary course of treatment or an augmentation to traditional talk therapies. You will learn how Muse can increase homework compliance and subsequently lead to both quantifiable and qualitative gains for your patients.
You will learn —
• How to implement Muse as either a primary focus in treatment or a complementary tool within your current treatment regime
• How to interpret Muse data to modify prescribed homework interventions and maintain ongoing therapeutic gains
• How to use Muse as an exit tool to extend success once a client has graduated from your practice
Ariel Garten, BSc, is the Founder and Chair of InteraXon, makers of Muse. Ariel studied neuroscience at the University of Toronto and worked in labs at Toronto’s Krembil Neuroscience Centre, researching Parkinson’s disease and hippocampal neurogenesis. She is also a fashion designer whose clothing opened Toronto Fashion Week in ’03, and she has had her work displayed at the Art Gallery of Ontario. Ariel’s uncommon combination of science and art is integral to the design of Muse and to InteraXon’s unique approach to brain-sensing technology. Ariel was trained in neuro-linguistic programming and is currently in private practice. She has also lectured about interdisciplinary neuroscience topics, such as “The Neuroscience of Morals” and “The Neuroscience of Molecular Gastronomy”, as well as psychotherapy and mental health.
Michael Decaire, MA, CPsych, RPsych, RP, is a clinician, trainer/educator, and consultant who has assisted hundreds of private practices and institutions explore their psychological/psychotherapeutic processes and the business of being a treatment provider. He is the founder of FLEX Psychology, which provides online and in-person treatment, as well as international consultation and training for treatment providers. He has an interest in integrating technology into and around the treatment process, and thus can respond to the high demand as a consultant for startups entering into that sector. His immersive role in health governance as a graduate-level educator and the President of the Ontario Association of Psychological Associates (OAPA) has allowed him to influence the direction of psychotherapy, while maintaining a focus on ethical and efficacious practice. Michael has been an invited speaker internationally at conferences and symposia for over 15 years; this will be his second time presenting on behalf of Leading Edge Seminars. He is also presenting 1 day seminar called “The Future of Psychotherapy Today: The Promise and Effectiveness of New Technology”
Graeme Moffat, PhD, leads neuroscience research and health and wellness applications for Muse. He has over a decade of research experience in psychology and neuroscience and in scientific management. Graeme served as managing editor of Frontiers in Neuroscience, the largest journal series in psychology and neuroscience, and of Frontiers in Neurology and Frontiers in Psychiatry. His experience has included research engineering at Neurelec/Oticon and graduate and post-graduate work at the National Scientific Research Centre (CNRS) in France. Graeme holds a PhD in neuroscience from Université Aix-Marseille. He is currently a TalentEdge Fellow of the the Ontario Centres of Excellence and a member of the Centre for Responsible Brainwave Technology (CeReB). In his spare time, Graeme throws frisbees and (occasionally) axes.
Laurie Wells, MD, is a physician who has worked in integrative medicine for over 25 years with a specialization in mental health care. She is passionate about blending old wisdom with modern technology and wellness-based integrative medicine counselling through tools such as MUSE and Heartmath and approaches such as exploring food as medicine and the therapeutic benefits of spending time in nature. With a background in teaching and research, she is presently working to further develop the multidisciplinary Metabolic Syndrome Program at Waypoint Centre for Mental Health Care, and a wellness-based curriculum for high school students. She is on faculty at the Institute for Healthcare Communication and is on the Consent and Capacity Board of Ontario.